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Psychopharmacology for the Clinician

The information in this column is not intended as a definitive treatment strategy but as a suggested approach for clinicians treating patients
with similar histories. Individual cases may vary and should be evaluated carefully before treatment is provided. The patient described in this
column is a composite with characteristics of several real patients.

Mixed depression in the postpartum
period: diagnostic and treatment issues
A 20-year-old married woman presented with a history of feeling depressed since the birth of her first child
3 weeks earlier. She had an uneventful
pregnancy and delivered a healthy
child, but felt she was not bonding
with the newborn. On questioning, she
reported loss of interest, crying spells,
decreased need for sleep, reduced
appetite, poor concentration, guilt,
increased goal-directed activity and
racing thoughts, but she denied any
thoughts of harm to herself or to
the newborn. She had no history of
psychiatric illness and did not have
any current symptoms of psychosis,
anxiety disorder or substance use disorder. She reported that her mother
has bipolar disorder. Physically, the
patient was healthy, and blood work
showed normal complete blood count
and thyroid functioning. She agreed
to consider drug treatment, but she
hoped to continue breastfeeding.
Diagnostic confirmation should be
the first step in the management of this
patient’s depression. Postpartum depression is a heterogeneous condition
that includes a mixture of depressions
with different etiologies, different clinical profiles and different responses to
treatment. Most (60%) women experience onset of depression during or before pregnancy rather than in the postpartum period.1 Our patient presented
with predominantly depressive symptoms and with at least 3 manic symptoms, including increased goal-directed
activity, racing thoughts and decreased
need for sleep. Thus, she met the DSM5 diagnostic criteria for major depressive disorder with mixed features specifier. The specifier requires the presence

of at least 3 hypomanic or manic symptoms that do not overlap with symptoms of major depression.2 A differential diagnosis of bipolar disorder
should be considered because about
22% of women with postpartum depression actually have bipolar disorder,1 but our patient did not have any
hypomanic or manic episodes. However, certain clinical features, including
younger age at illness onset, family history of bipolar disorder, postpartum
onset and the presence of manic features in the current episode of depression, suggested that she would be at
risk for bipolar disorder.3,4
Treatment options include psychotherapy and pharmacotherapy.
Psycho therapy is generally recommended for mild to moderate postpartum depression, whereas pharmacotherapy alone or in combination
with psychotherapy is usually reserved
for moderate to severe postpartum depression. Antidepressants are commonly used to treat postpartum depression, but should be used with
caution in patients with a first episode
of depression in the postpartum period
and/or family history of bipolar disorder.3 There are no controlled trials of
mood stabilizers in women with postpartum depression. Compatibility of
the selected drug with breastfeeding
and its effectiveness in mixed depression should be an important consideration in our patient’s case. The presence
of subsyndromal manic symp toms
indicates that she may be at risk for
treatment-emergent mania following
treatment with antidepressants. 5,6
Lithium is not particularly effective in
patients with mixed depression, but it
can be used cautiously during lactation
with attention to the infant’s hydration
and monitoring of renal and thyroid

function. Lamotrigine can be efficacious in some patients with depression
but it takes at least 4–6 weeks to reach
the optimum dosage of lamotrigine.
Owing to its efficacy in patients with
mania and depression, a trial of quetiapine is a good option. There are no
studies of atypical antipsychotics in the
management of postpartum depression, but quetiapine is effective in the
management of both unipolar and
bipolar depressions.7 The American
Congress of Obstetricians and Gynecologists guidelines list quetiapine
use as possibly hazardous during lactation.8 Lamotrigine should be used
cautiously because of concerns about
skin rash in the infant after exposure
through breastfeeding.9 Psychoeducation should incorporate a discussion of
the patient’s diagnosis, treatment plan
and expected outcome. Help with nocturnal infant care should be recommended to minimize the patient’s sleep
disruption. Once the patient’s condition is stable, issues such as parenting
skills and mother–infant bonding
should be addressed.
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